Daniel Barocas

Daniel Barocas, M.D., associate professor of Urologic Surgery, recently received the Society of Urologic Oncology’s (SUO) Young Investigator Award at the group’s 2017 annual meeting in Boston. Read More

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA). Read More

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men. Read More

Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery at Vanderbilt University Medical Center, was recently named a representative on the Commission on Cancer. Read More

The overuse of many medical tests and interventions wastes money and can actually harm patients, say more than two dozen medical societies. Daniel Barocas, assistant professor of urology, is quoted. Read More

Racial differences exist in quality surgical care, new research from VICC finds. Read More

Severity of cancer could be predicted by prostate size. Read More